You just read:

Lumosa Announces FDA Acceptance of IND Application for LT1001, an Extended-Release Analgesic Injection - Lumosa to Initiate the Bridging Study in the US

News provided by

Lumosa Therapeutics Co., Ltd.

Dec 03, 2019, 04:36 ET